Recursion Pharmaceuticals Inc. stock reached a 52-week low, closing at $2.98. The biotechnology company, with a market capitalization of $1.58 billion, now trades 58% below its 52-week high of $7.18.

NEW YORK and SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) — Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion ...

After a four-month midseason hiatus, Invincible returns this week for the second half of its second season. The emotionally charged, animated superhero series, which will air four more episodes as ...

Warning: this article contains spoilers for Dune: Part 2! Check out our spoiler-free review of Dune: Part 2. There was a guy sitting two rows behind me at my screening of Dune: Part 2 who, as the ...

Rei Penber is the Deputy Lead Editor for GameRant's Anime and Manga team, originally from Kashmir and currently based in Beirut. He brings seven years of professional experience as a writer and editor ...

Season 3 of Jujutsu Kaisen has lived up to its hype, thanks to director Shōta Goshozono’s brilliant storyboarding and Mappa’s impressive creative direction. Hot on the heels of the season 3 finale, ...

Madonna is returning to the discothèque. Two decades after the release of her beloved album Confessions on a Dance Floor, the Queen of Pop has been hard at work on a sequel. “I’m putting my heart and ...